与乳腺癌多基因风险相关的代谢物
Elizabeth Samuels1,2, Jaclyn Parks1, Jessica Chu1
1Cancer Control Research, BC Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada.
Metabolites
|June 26, 2024
概括
乳腺癌的遗传风险与特定的血液代谢物有关,主要是像VLDL和HDL这样的脂蛋白. 这些发现表明,高风险女性的干预措施可能是潜在的目标.
科学领域:
- 遗传学 是一个遗传学.
- 代谢学 代谢学 代谢学
- 生物化学 生物化学
背景情况:
- 数百种基因变异与乳腺癌风险有关,但潜在的机制往往不清楚.
- 代谢学可以阐明受癌症遗传倾向影响的生物途径.
- 脂质代谢越来越被认为是癌症发展的一个因素.
研究的目的:
- 研究乳腺癌的多基因风险评分 (PRS) 与血液代谢物水平之间的关联.
- 确定可能调解遗传风险和乳腺癌之间的关系的特定代谢物.
- 探索通过代谢变化将遗传倾向与乳腺癌联系在一起的潜在机制.
主要方法:
- 在143名没有癌症的女性参与者中利用线性回归分析.
- 使用多基因风险评分 (PRS) 评估乳腺癌遗传风险,其中包括266个单核酸多态 (SNP).
- 使用核磁共振 (NMR) 谱学量化了223种血液代谢物,在多次比较中应用了10%的错误发现率.
主要成果:
- 在乳腺癌PRS和45种代谢物测量 (q = 0.1) 之间发现了统计学上显著的关联.
- 受影响的代谢物主要与非常低密度脂蛋白 (VLDL) 和高密度脂蛋白 (HDL) 相关,包括甘油三,胆固醇和脂.
- 观察到最强的关联是中等VLDL甘油三和总脂质的百分比,显示每单位PRS增加0.53个单位的增加.
结论:
- 这项探索性研究确定了乳腺癌遗传风险和特定脂质代谢物之间的显著关联.
- 研究结果表明,VLDL和HDL代谢的改变可能在遗传倾向的个体中起到乳腺癌发展的作用.
- 确定的关联可以为针对性生活方式或药物干预为患有乳腺癌遗传风险较高的妇女铺平道路.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
Cancer-Critical Genes I: Proto-oncogenes
8.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


